Full Text View
Tabular View
No Study Results Posted
Related Studies
AG014699 in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer
This study is currently recruiting participants.
Study NCT00664781   Information provided by National Cancer Institute (NCI)
First Received: April 22, 2008   Last Updated: August 1, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
brca1 Mutation Carrier
brca2 Mutation Carrier
Breast Cancer
Ovarian Cancer
Additional conditions recognized in this trial
Breast Neoplasms
Ovarian Neoplasms
More general conditions related to this trial
Adnexal Diseases
Breast Diseases
Endocrine Gland Neoplasms
Endocrine System Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Gonadal Disorders
Neoplasms
Neoplasms by Site
Ovarian Diseases
Skin Diseases
Urogenital Neoplasms
Interventions listed in this trial
PARP-1 inhibitor AG014699
protein expression analysis
western blotting
liquid chromatography
mass spectrometry
pharmacological study
Sponsors listed in this trial
Cancer Research UK


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services